Numerous studies have now been published confirming the high prevalence of epilepsy in people with intellectual disabilities (ID).1–3 McDermott and colleagues3 compared the rates of epilepsy between ID and non-ID groups living in the community. The non-LD group had an epilepsy prevalence rate of 1%. The prevalence of epilepsy within the LD group was 13% for cerebral palsy, 13.6% for Down syndrome (DS), 25.4% for autism, 25.5% for mental retardation, and 40% for adults with both cerebral palsy and ID. Further, the researchers found that during the decades of adulthood, the prevalence of epilepsy declined for those with cerebral palsy and ID. The prevalence of epilepsy increased with advancing years for adults with DS and autism. For each decade, the prevalence of epilepsy was higher in the ID group compared to the non-ID group.
A significant proportion of persons with ID will have intractable epilepsy. Antiepileptic drugs (AEDs) remain the principal form of management for intractable epilepsy with up to 40% of individuals on polytherapy. However, poor seizure control may still be evident, leading to the consideration of alternative treatments. The principal alternative form of treatment is psychosurgery, but this is not readily accessible to persons with ID. Vagus nerve stimulation (VNS) therapy has the potential to be the main practical and efficacious treatment alternative to AEDs for individuals with ID who suffer from intractable epilepsy. To date there is very limited information specifically focused on the role of VNS Therapy to treat epilepsy in the ID population. This review chapter examines the role of VNS Therapy in persons with ID.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Coulter DL. (1993) Epilepsy and mental retardation: An overview. Am J Ment Retard. 98: 1-11.
Bowley C, Kerr M. (2000) Epilepsy and intellectual disability. J Intellect Disabil Res 44: 529-543.
McDermott S, Moran R, Platt T, et al. (2005) Prevalence of epilepsy in adults with mental retardation and related disabilities in primary care. Am J Ment Retard 110: 48-56.
Espie CA, Gillies JB, Montgomery JM. (1990) Antiepileptic polypharmacy, psychosocial behaviour and locus of control orientation among mentally handicapped adults living in the community. J Ment Defic Res. 34: 351-360.
Singh BK, Towle PO. ( 1993) Antiepileptic drug status in adult outpatients with mental retar- dation. Am J Ment Retard 98: 41-46.
Zabara J. (1985) Peripheral control of hypersynchronous discharge in epilepsy. Electroencephal Clin Neurophysiol. 61: 162.
Zanchetti A, Wang SC, Moruzzi G. (1952) Effect of afferent vagal stimulation on the electroencephalogram of the cat in cerebral isolation. B Soc Ital Biol Sper. 28: 627-628.
Chase MH, Sterman MB, Clemente CD. ( 1966) Cortical and subcortical patterns of response to afferent vagal stimulation. Exper Neurol. 16: 36-49.
Woodbury DM, Woodbury JW. (1990) Effects of vagal stimulation on experimentally induced seizures in rats. Epilepsia 31: S7-s19.
Lockard JS, Congdon WC, DuCharme LL. (1990) Feasibility and safety of vagal stimulation in monkey model. Epilepsia 31: S20-s26.
Penry JK, Dean JC. (1990) Prevention of intractable partial seizures by intermittent vagal stimulation in humans: Preliminary results. Epilepsia 31: S40-s43.
Binnie CD. (2000) Vagus nerve stimulation for epilepsy: A review. Seizure 9: 161-169.
Vonck K, Laere K, Van Dedeurwaerdere ST, et al. et al. (2001) The mechanism of action of vagus nerve stimulation for refractory epilepsy. J Clin Neurophysiol 18: 394-401.
Henry TR. (2002) Therapeutic mechanisms of vagus nerve stimulation. Neurology. 59: S3-S14.
Rutecki P. (1990) Anatomical, physiological, and theoretical basis for the antiepileptic effect of vagus nerve stimulation. Epilepsia 31: S1-s6.
Boon P, Vonck K, Reuck J, et al. De et al. (2001) Vagus nerve stimulation for refactory epilepsy. Seizure 10: 448-455.
Krahl SE, Clark KB, Smith DC, et al. et al. (1998) Locus coeruleus lesions suppress the seizure-attenuating effects of vagus nerve stimulation. Epilepsia 39: 709-714.
Amar AP, Heck CN, DeGiorgio, CM, et al. et al. (1999). Experience with vagus nerve stimulation for intractable epilepsy: Some questions and answers. Neurol Med Chir (Tokyo) 39: 489-495.
Ben-Menachem E. (1996) Vagus nerve stimulation. Bailliere’s Clin Neurol 5: 841-848.
Hammond EJ, Uthman BM, Reid SA, et al. et al. (1992) Electrophysiological studies of cervical vagus nerve stimulation in humans: I. EEG effects. Epilepsia 33: 1013-1020.
Henry TR. (1998) 10 most commonly asked questions about vagus nerve stimulation for epilepsy. Neurologist 39: 677-686.
Vonck K, Boon P, Laere K, et al. Van et al. (2000) Acute single photon emission computed tomographic study of vagus nerve stimulation in refractory epilepsy. Epilepsia 41: 601-609.
Olejnieczak PW, Fisch BJ, Carey M, et al. (2001) The effect of vagus nerve stimulation on epileptiform activity recorded from hippocampal depth electrodes. Epilepsia 42: 423-429.
Koo B. (2001) EEG changes with vagus nerve stimulation. J Clin Neurophysiol 18: 434-441.
Salinsky MC, Burchiel KJ. (1993) Vagus nerve stimulation has no effect on awake EEG rhythms in humans. Epilepsia 34: 299-304.
Vonck K, Thadani V, Gilbert K, et al. (2004) Vagus nerve stimulation for refractory epilepsy: A transatlantic experience. J Clin Neurophysiol 21: 283-289.
Uthman BM., Wilder BJ, Hammond EJ, et al. (1990) Efficacy and safety of vagus nerve stimulation in patients with complex partial seizures. Epilepsia 31: S44-s50.
Uthman BM, Wilder BJ, Penry JK, et al. (1993) Treatment of epilepsy by stimulation of the vagus nerve. Neurology 43: 1338-1345.
The Vagus Nerve Stimulation Study Group. (1995) A randomized controlled trial of chronic vagus nerve stimulation for treatment of medically intractable seizures. Neurology 45: 224-230.
Amar AP, Heck CN, Levy ML, et al. (1998) An institutional experience with cervical vagus nerve trunk stimulation for medically refactory epilepsy: Rationale, technique, and outcome. Neurosurgery 43: 1265-1280.
Handforth A, DeGiorgio CM, Schachter, et al. (1998) Vagus nerve stimulation therapy for partial-onset seizures. Neurology 51: 48-55.
Salinsky MC, Uthman BM, Ristanovic RK, et al. (1996) The Vagus Nerve Stimulation Study Group. Vagus Nerve Stimulation for the Treatment of Medically Intractable Seizures. Arch Neurol 53: 1176-1180.
Morris GL, Mueller WM. The Vagus Nerve Stimulation Group E01 -E05. (1999) Long-term treatment with vagus nerve stimulation in patients with refractory epilepsy. Neurology 53: 1731-1735.
DeGiorgio CM, Schachter SC, Handforth A, et al. (2000) Prospective long-term study of vagus nerve stimulation for the treatment of refactory seizures. Epilepsia. 41: 1195-1200.
Alexopoulos AV, Kotagal P, Loddenkemper T, et al. (2006) Long-term results with vagus nerve stimulation in children with pharmacoreresistant epilepsy. Seizure. 15: 491-503.
Parker APJ, Polkey CE, Binnie CD, et al. (1999) Vagal nerve stimulation in epileptic encephalopathies. Pediatrics 1003: 778-782.
Lundgren J, Amark P, Blennow G, et al. (1998) Vagus nerve stimulation in 16 children with refractory epilepsy. Epilepsia 39: 809-813.
Murphy JV, Pediatric VNS Study Group. (1999) Left vagal nerve stimulation in children with medically refractory epilepsy. J Pediatr 34: 563-566.
Frost M, Gates J, Helmers SL, et al. (2001) Vagus nerve stimulation in children with refactory seizures associated with Lennox-Gastaut syndrome. Epilepsia 42: 1148-1152.
Benifla M, Rutka JT, Logan W, et al. (2006). Vagal nerve stimulation for refractory epilepsy in children: Indications and experience at The Hospital for Sick Children. Child Nerv Syst 22: 1018-1026.
Rychlicki F, Zamponi N, Trignani R, et al. (2006) Vagus nerve stimulation: Clinical experience in drug-resistant pediatric epileptic patients. Seizure 15: 483-490.
Helmers SL, Wheless JW, Frost M, et al. (2001) J Child Neurol 16: 843-848.
Majoie HJM, Berfelo MW, Aldenkamp AP, et al. (2001) Vagus nerve stimulation in children with therapy-resistant epilepsy diagnosed as Lennox-Gastaut syndrome. J Clin Neurophysiol 18: 419-428.
Aldenkamp AP, Veerdonk SHA, Van de Majoie HJM, et al. et al. (2001) Effects of 6 months of treatment with vagus nerve stimulation on behavior in children with Lennox-Gastaut syndrome in an open clinical and nonrandomized study. Epilepsy Behav 2: 343-350.
Nagarajan L, Walsh NL, Gregory P, et al. (2002) VNS Therapy in clinical practice in children with refractory epilepsy. Acta Neurol Scand 105: 13-17.
Andriola MR, Vitale A. ( 2001) Vagus nerve stimulation in the developmentally disabled. Epilepsy Behav 2: 129-134.
Hornig GW, Murphy JV, Schallert G, et al. (1997) Left vagus nerve stimulation in children with refractory epilepsy: An update. South Med J 90: 484-488.
Park YD. (2003) The effects of vagus nerve stimulation therapy on patients with intractable seizures and either Landau-Kleffner syndrome or autism. Epilpesy Behav 4: 286-290.
Kanner L. (1943) Autistic disturbances of affective contact. Nervous Child 2: 217-250.
Casazza M, Avanzini G, Ferroli P, et al. (2006) Vagal nerve stimulation: Relationship between outcome and electroclinical seizure pattern. Seizure 15: 198-207.
Buoni S, Mariottini A, Pieri S, et al. (2004) Vagus nerve stimulation for drug-resistant epilepsy in children and young adults. Brain Dev 26: 158-163.
Hosain S, Nikalov B, Harden, C, et al. (2000). Vagus nerve stimulation treatment for LennoxGastaut syndrome. J Child Neurol 15: 509-512.
Ben-Menachem E, Hellstrom K, Waldton C. (1999) Evaluation of refractory epilepsy treated with vagus nerve stimulation for up to 5 years. Neurology 52: 1265-1267.
Atkins L, Miller, WL, Salam M. (1972) A ring-20 chromosome. J Med Genet 9: 377-380.
Chawla J, Sucholeiki R, Jones C, et al. (2002) Intractable epilepsy with ring chromosome 20 syndrome treated with vagal nerve stimulation: Case report and review of the literature. J Child Neurol 17: 778-780.
Alpman A, Serdaroglu G, Cogulu, O, et al. (2005) Ring chromosome 20 syndrome with intractable epilepsy. Dev Med Child Neurol 48: 80.
Parr JR, Pang K, Mollett A, et al. (2006) Epilepsy responds to vagus nerve stimulation in ring chromosome 20 syndrome. Dev Med Child Neurol 48: 80.
Thiele EA. ( 2004) Managing epilepsy in tuberous sclerosis complex. J Child Neurol 19: 680-686.
Parain D, Penniello MJ, Berquen, P. (2001) Vagal nerve stimulation in tuberous sclerosis complex patients. Pediatr Neurol 25: 213-216.
Wilfong AA, Schultz RJ. ( 2006) Vagus nerve stimulation for treatment of epilepsy in Rett syndrome. Dev Med Child Neurol 48: 683-686.
Matthews, K, Elijamel MS. (2003) Vagus nerve stimulation and refractory depression: Please can you switch me on doctor? Br J Psychiatr 183: 181-183.
Ben-Menachem E. (2001). Vagus nerve stimulation, side effects, and long term safety. (2001). J Clin Neurophysiol. 18: 415-418.
Lockard JS, Ojemann GA, Congdon WC, et al. (1979). Cerebellar stimulation in aluminagel monkey model: inverse relationship between clinical seizures and EEG interictal bursts. Epilepsia 20: 223-234.
Tatum, WO, 4th, Moore DB, Stecker MM, et al. (1999) Ventricualr asystole during vagus nerve stimulation for epilepsy in humans. Neurology 52: 1267-1269.
Asconape JJ, Moore DD, Zipes DP, et al. (1999) Bradycardia and asystole with the use of vagus nerve stimulation for the treatment of epilepsy: A rare complication of intraoperative device testing. Epilepsia 40: 1452-1454.
Zalvan C, Sulica L, Wolf S, et al. (2003) Laryngopharyngeal dysfunction from the implant vagal nerve stimulator. Laryngoscope 113: 221-225.
Kersing W, Dejonckere PH, Aa, HE, et al. van der et al. (2002) Laryngeal and vocal changes during vagus nerve stimulation in epileptic patients. J Voice 16: 251-257.
Charous SJ, Kempster G, Manders, E, et al. (2001) The effect of vagal nerve stimulation on voice. Laryngoscope. 111: 2028-2031.
Lundgren J, Ekberg O, Olsson, R. (1998) Aspiration: A potential complication to vagus nerve stimulation. Epilepsia 39: 998-1000.
Annegers JF, Coan SP, Hauser WA, et al. (2000) Epilepsy, vagal nerve stimulation by the NCP system, all-cause mortality, and sudden, unexpected, unexplained death. Epilepsia 41: 549-553.
Espinosa J, Aiello MT, Naritoku DK. ( 1999) Revision and removal of stimulating electrodes following long-term therapy with the vagus nerve stimulator. Surg Neurol 51: 659-664.
Ramsay RE, Uthman BM, Augustinsson LE, et al. (1994). Vagus nerve stimulation for treatment of partial seizures: 2. Safety, side effects, and tolerability. First International Vagus Nerve Stimulation Study Group. Epilepsia 1994. 35: 627-636.
Kuba R, Guzaninova M, Brazdil M, et al. (2002) Effect of vagal nerve stimulation on interictal epileptiform discharges: A scalp EEG study. Epilepsia 43: 1181-1188.
Marrosu F, Santoni F, Puligheddu M, et al. (2005) Increase in 20 -50 Hz (gamma frequencies) power spectrum and synchronization after chronic vagal nerve stimulation. Clin Neurophysiol 116: 2026-2036.
Narayanan JT, Watts R, Haddad N, et al. (2002) Cerebral activation during vagus nerve stimulation: A functional MR study. Epilepsia 43: 1509-1514.
Sucholeiki R, Alsaadi TM, Morris GL. (2002) fMRI in patients implanted with a vagal nerve stimulator. Seizure 11: 157-162.
Liu WC, Mosier K, Kalnin AJ, et al. (2003) BOLD f MRI activation induced by vagus nerve stimulation in seizure patients. J Neurol Neurosurg Psychiatr 74: 811-813.
Barnes A, Duncan R, Chisholm JA. (2003) Investigation into the mechanisms of vagus nerve stimulation for the treatment of intractable epilepsy, using 99mTc-HMPAO SPECT brain images. Eur J Nucl Med Mol Imaging 30: 301-305.
Ring HA, White S, Costa DC, et al. (2000) A SPECT study of the effect of vagal nerve stimulation on thalamic activity in patients with epilepsy. Seizure 9: 380-384.
Tatum WO, Johnson KD, Goff S, et al. (2001) Vagus nerve stimulation and drug reduction. Neurology 56: 561-563.
Jacoby A, Buck D, Baker G, et al. (1998) Uptake and costs of care for epilepsy: Findings from a U.K. regional study. Epilepsia 39: 776-786.
Boon P, Vonck K, D’Have M, et al. (1999) Cost-benefit of vagus nerve stimulation for refactory epilepsy. Acta Neurol Bel 99: 275-280.
Boon P, D’Have MD, Walleghem P, et al. Van et al. (2002) Direct medical costs of refactory epilepsy incurred by three different treatment modalities: A prospective assessment. Epilepsia 43: 96-102.
Malow BA, Edwards J, Marzec M, et al. (2001) Vagus nerve stimulation reduces daytime sleepiness in epilepsy patients. Neurology 57: 879-884.
Roslin M, Kurian M. (2001) The use of electrical stimulation of the vagus nerve to treat morbid obesity. Epilepsy Behav. 2: S11-S16.
Sobocki J, Krolczyk G, Herman RM, et al. (2005) I nfluence of vagal nerve stimulation on food intake and body weight — results of experimental studies. J Physiol Pharmacol. 56: 27-33.
Clarke KB, Naritoku DK, Smith DC, et al. (1999). Enhanced recognition memory following vagus nerve stimulation in human subjects. Nature Neurosci 2: 94-98.
Sackeim HA, Keilp JG, Rush AJ, et al. (2001) The effects of vagus nerve stimulation on cognitive performance in patients with treatment-resistant depression. Neuropsy Neuropsy Be 14: 53-62.
Harden CL, Pulver MC, Ravdin LD, et al. (2000) A pilot study of mood in epilepsy patients treated with vagus nerve stimulation. Epilepsy Behav. 1: 93-99.
Hoppe C, Helmstaedter C, Scherrmann J, et al. (2001) Self-reported mood changes fol- lowing 6 months of vagus nerve stimulation in epilepsy patients. Epilepsy Behav 2: 335-342.
Elger G, Hoppe C, Falkai, P, et al. (2000) Vagus nerve stimulation is associated with mood improvements in epilepsy patients. Epilepsy Res 42: 203-210.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer Science + Business Media, LLC
About this chapter
Cite this chapter
Prasher, V.P., Furlong, E., Weerasena, L. (2008). Vagus Nerve Stimulation Therapy: An Intellectual Disabilities Perspective. In: Prasher, V.P., Kerr, M.P. (eds) Epilepsy and Intellectual Disabilities. Springer, London. https://doi.org/10.1007/978-1-84800-259-3_8
Download citation
DOI: https://doi.org/10.1007/978-1-84800-259-3_8
Publisher Name: Springer, London
Print ISBN: 978-1-84800-258-6
Online ISBN: 978-1-84800-259-3
eBook Packages: MedicineMedicine (R0)